AKBA R&D to Revenue
Akebia Therapeutics Inc · R&D to Revenue
AKBA R&D to Revenue
Latest reported26.40%period ending
AKBA FY R&D/Revenue (0.00% → 26.40%)
Latest values, visible window
High-resolution chart · PNG
AKBA r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 26.4014% | |
| 23.5061% | |
| 32.4109% | |
| 56.7505% | |
| 69.8568% | |
| 74.1522% | |
| 96.4084% | |
| 140.1103% | |
| 129.7268% | |
| 7,542.9967% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |